Luis Caraballo

Luis Caraballo


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2012 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
RDRodolfo J Dennis
Rodolfo J Dennis
LCLuis Caraballo
Luis Caraballo
EGElizabeth García
Elizabeth García
MRMaría X Rojas
María X Rojas
MRMARTIN RONDON
MARTIN RONDON
SJSilvia Jimenez
Silvia Jimenez
While it is suggested that the prevalence of asthma in developed countries may have stabilized, this is not clear in currently developing countries. Current available information for both adults and children simultaneously on the burden and impact of allergic conditions in Colombia and in many Latin American countries is limited. The objectives of this study were to estimate the prevalence for asthma, allergic rhinitis (AR), atopic eczema (AE), and atopy in six colombian cities; to quantify costs to the patient and her/his family; and to determine levels of Immunoglobulin E (IgE) in asthmatic and healthy subjects.

1 January 2017 in World Allergy Organization Journal
Verified
Journal Article
Open access
PDF file
EHElham Hossny
Elham Hossny
LCLuis Caraballo
Luis Caraballo
TCThomas B Casale
Thomas B Casale
YEYehia El-Gamal
Yehia El-Gamal
LRLanny Rosenwasser
Lanny Rosenwasser
Severe asthma has a great impact on the quality of life (QOL) of patients and their families. The magnitude of this morbidity is affected by several personal factors including age. Appropriate asthma control and modifications of social roles and activities are expected to improve QOL. Biologics, primarily monoclonal antibodies, have been developed to target specific pathways and molecules important in the pathogenesis of asthma. The use of biologics has shown some promising effects on the QOL of patients with severe recalcitrant asthma. Other potential measures involve targeting risk factors and comorbidities and improving the levels of adherence to therapy. This article briefly reviews the impact of severe asthma on QOL and the potential methods to combat this morbidity including the available therapeutic biologics.

1 January 2011 in Frontiers in Bioscience-Elite
Verified
Journal Article
Closed access
LCLuis Caraballo
Luis Caraballo
NANathalie Acevedo
Nathalie Acevedo
Allergic diseases and nematode infections such as ascariasis are important health problems in underdeveloped tropical countries. The co-exposure to Ascaris lumbricoides and the domestic mites Blomia tropicalis and Dermatophagoides pteronyssinus induces a strong Th2 and immunomodulatory responses that can modify the natural history of both diseases. An associate phenomenon of these particular environmental conditions is cross reactivity between mite and Ascaris allergens. We demonstrated a high IgE cross reactivity between the allergenic extracts from both sources and that several already known allergens like tropomyosin and glutathione-s-tranferases are involved. Although this cross reactive antibody response has not been completely analyzed, there are clinical and experimental evidences suggesting that it could be an important component of the complex interactions between ascariasis and mite allergy. For example, it may affect the specificity of serological IgE tests for diagnosing both ascariasis and allergic diseases and, in consequence, the results of epidemiological surveys evaluating the predisposing or protecting role of ascariasis on allergy. In this review we discuss the potential role of cross reactivity on several aspects of allergy in the tropics that have been the matter of a number of investigations, some of them with controversial results.

10 February 2012 in IATREIA
Verified
Journal Article
Open access
PDF file
CVCandelaria Vergara
Candelaria Vergara
JSJorge Sánchez
Jorge Sánchez
BMBeatriz Martínez
Beatriz Martínez
LCLuis Caraballo
Luis Caraballo
El asma es una enfermedad respiratoria crónica con alta heredabilidad. Se ha propuesto que en su patogénesis participan varios genes con efectos variables al igual que factores ambientales, y se ha sugerido que los mecanismos epigenéticos pueden mediar parte del efecto de los factores ambientales en el comienzo y la evolución de la enfermedad. La epigenética describe los cambios en la expresión génica heredables durante las mitosis y meiosis que no son codificados en la secuencia de ADN. Ellos incluyen la metilación o desmetilación del ADN y la acetilación, desacetilación, ubiquitinación, sumoilación y fosforilación de histonas, cambios en los microARN y alteraciones cromatínicas. En esta revisión se describen hallazgos que establecen una relación entre algunos mecanismos epigenéticos y el proceso inflamatorio y la exposición a factores ambientales en el asma. Ellos incluyen: el aumento en la actividad de las acetilasas de histonas y de la expresión de las enzimas acetiladoras; la disminución de las enzimas desacetiladoras en los pulmones de individuos asmáticos; el aumento de la expresión del factor nuclear NF-κB durante el proceso inflamatorio alérgico; cambios en la metilación/desmetilación del ADN durante la diferenciación de los linfocitos y la estimulación/supresión de genes como los de la IL-4 y el IFN-γ, respectivamente. El humo del cigarrillo, las infecciones bacterianas y virales, la dieta materna y la polución ambiental son otros factores que desencadenan procesos epigenéticos como la acetilación de histonas, la inducción de citoquinas inflamatorias, la inactivación de las desacetilasas de histonas, la polarización de la respuesta inmune hacia el tipo Th2 y una mayor producción de IgE y citoquinas de este perfil. Se revisan también los efectos epigenéticos resultantes de la terapia con corticoides y teofilina y otros factores que podrían influir en el riesgo de asma en la infancia como la ingesta materna de frutas, legumbres, aceites de pescado, vitaminas, minerales y probióticos y el uso de antibióticos durante el embarazo.